Nexipox Plus® (Varicella Vaccine, Live I.P.) is a specialized vaccine developed by Novo Medi Sciences for the prevention of Chickenpox. It is formulated with an advanced Trehalose stabilizer and is notably Gelatin-free, ensuring high stability and a reduced risk of allergic reactions.

🛡️ Key Uses & Benefits
Active Immunization: Indicated for the prevention of infection caused by the Varicella-Zoster virus (Chickenpox).

Post-Exposure Prophylaxis: Can be administered within 72 hours of exposure to prevent or significantly reduce the severity of the disease.

Complication Prevention: Guards against secondary infections like bacterial skin infections, pneumonia, and encephalitis.

Enhanced Stability: The 2X Trehalose Protection ensures the vaccine remains potent even if minor cold-chain fluctuations occur.

📅 Vaccination Schedule
Children (12 months to 12 years): A two-dose regimen is standard. The first dose is typically given at 15 months, and the second dose between 4 to 6 years (or a minimum gap of 3 months).

Adolescents & Adults (13+ years): Two doses administered at an interval of 4 to 8 weeks for those with no evidence of immunity.

💉 Dosage & Administration
Route: Administered strictly via Subcutaneous (SC) injection.

Volume: Single dose of 0.5 ml after reconstitution with the provided sterile diluent.

Reconstitution: Must be used immediately or within 30 minutes of mixing to maintain efficacy.